Rebopag 25 Mg (Eltrombopag)
| Active Ingredient | Eltrombopag |
|---|---|
| Indication: | Low platelet count due to ITP or HCV infection |
| Manufacturer: | MSN Laboratories |
| Packaging | 7 tablets in 1 strip |
| Strength | 25mg |
| Delivery Time | 6 To 15 days |
Rebopag 25 mg is a prescription medicine that contains Eltrombopag, used to treat low platelet counts in patients with chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, and severe aplastic anemia. Eltrombopag is a thrombopoietin receptor agonist that works by stimulating the bone marrow to increase platelet production, thereby reducing the risk of bleeding episodes.
This medication is generally prescribed when first-line treatments like corticosteroids or immunoglobulins fail. It is taken orally, often on an empty stomach, and dosage should be strictly followed as advised by a healthcare provider. Regular monitoring through blood tests is recommended to ensure safe and effective use. Rebopag 25 mg offers patients an effective solution for managing chronic platelet disorders, improving both platelet levels and quality of life.











There are no reviews yet.